The effect of increasing body mass index on cardio-metabolic risk and biomarkers of oxidative stress and inflammation in nascent metabolic syndrome.
暂无分享,去创建一个
[1] Mahmi Fujimori,et al. Melatonin Action on the Activity of Phagocytes from the Colostrum of Obese Women , 2019, Medicina.
[2] T. Pawlik,et al. Circulating monocyte chemoattractant protein‐1 (MCP‐1) is associated with cachexia in treatment‐naïve pancreatic cancer patients , 2018, Journal of cachexia, sarcopenia and muscle.
[3] E. Levy,et al. Metabolic Syndrome as a Multifaceted Risk Factor for Oxidative Stress. , 2017, Antioxidants & redox signaling.
[4] E. Heggen,et al. Characteristics of Metabolic Syndrome in Morbidly Obese Subjects. , 2016, Metabolic syndrome and related disorders.
[5] H. Robberecht,et al. Biomarkers of Metabolic Syndrome: Biochemical Background and Clinical Significance. , 2016, Metabolic syndrome and related disorders.
[6] M. Fernández,et al. A Larger Body Mass Index is Associated with Increased Atherogenic Dyslipidemia, Insulin Resistance, and Low-Grade Inflammation in Individuals with Metabolic Syndrome. , 2015, Metabolic syndrome and related disorders.
[7] C. Apovian,et al. Pharmacological management of obesity: an endocrine Society clinical practice guideline. , 2015, The Journal of clinical endocrinology and metabolism.
[8] B. Adams-Huet,et al. Circulating pathogen-associated molecular pattern - binding proteins and High Mobility Group Box protein 1 in nascent metabolic syndrome: implications for cellular Toll-like receptor activity. , 2014, Atherosclerosis.
[9] G. Bray,et al. American association of clinical endocrinologists and american college of endocrinology position statement on the 2014 advanced framework for a new diagnosis of obesity as a chronic disease. , 2014, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[10] Robert F Kushner,et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. , 2014, Journal of the American College of Cardiology.
[11] G. Plourde,et al. Current issues in the identification and treatment of metabolically healthy but obese individuals. , 2014, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[12] Janusz Wnek,et al. 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults , 2013, Circulation.
[13] S. Devaraj,et al. Toll-like receptor status in obesity and metabolic syndrome: a translational perspective. , 2014, The Journal of clinical endocrinology and metabolism.
[14] B. Schultes,et al. Waist Circumference and Related Anthropometric Indices Are Associated with Metabolic Traits in Severely Obese Subjects , 2014, Obesity Surgery.
[15] B. Klop,et al. Dyslipidemia in Obesity: Mechanisms and Potential Targets , 2013, Nutrients.
[16] B. Adams-Huet,et al. Increased cellular and circulating biomarkers of oxidative stress in nascent metabolic syndrome. , 2012, The Journal of clinical endocrinology and metabolism.
[17] S. Devaraj,et al. Increased Toll-Like Receptor Activity in Patients With Metabolic Syndrome , 2012, Diabetes Care.
[18] S. Devaraj,et al. Adipose tissue dysregulation in patients with metabolic syndrome. , 2011, The Journal of clinical endocrinology and metabolism.
[19] J. Faintuch,et al. Inflammation and Biochemical Features of Bariatric Candidates: Does Gender Matter? , 2011, Obesity surgery.
[20] F. Tinahones,et al. Obesity and Insulin Resistance-Related Changes in the Expression of Lipogenic and Lipolytic Genes in Morbidly Obese Subjects , 2010, Obesity surgery.
[21] S. Msika,et al. Traditional Anthropometric Parameters Still Predict Metabolic Disorders in Women With Severe Obesity , 2010, Obesity.
[22] G. Marchesini,et al. Metabolic Syndrome and Insulin Resistance in Subjects with Morbid Obesity , 2010, Obesity surgery.
[23] S. Grundy,et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As , 2009, Circulation.
[24] U. Singh,et al. Human C-reactive protein and the metabolic syndrome , 2009, Current opinion in lipidology.
[25] J. Levy,et al. Use and abuse of HOMA modeling. , 2004, Diabetes care.